Abstract

Agonist-promoted regulation of the uridine nucleotide-activated human P2Y4 receptor (P2Y4-R) and P2Y6 receptor (P2Y6-R) was studied. Incubation of P2Y4-R-expressing 1321N1 human astrocytoma cells with the cognate agonist UTP resulted in rapid desensitization of the inositol phosphate response and a 50% loss of cell surface receptors. In contrast, incubation of P2Y6-R-expressing cells with the cognate agonist UDP caused neither rapid desensitization nor rapid loss of cell surface receptors. Removal of UTP from the medium of UTP-pretreated cells resulted in rapid and complete recovery of surface P2Y4-R even after 12 h of agonist treatment. Although extended incubation with UDP also caused a loss of surface P2Y6-R, rapid recovery of surface P2Y6-R did not occur following removal of agonist. Pharmacological studies indicated that neither protein kinase C nor other Ca(2+)-activated kinases were involved in agonist-promoted desensitization or loss of surface P2Y4-R or P2Y6-R. Mutational analyses were carried out to identify domains involved in agonist-dependent regulation of P2Y4-R. Sequential truncation of the carboxyl-terminal domain revealed that sequence between amino acids 332 and 343 was necessary for UTP-promoted desensitization and internalization. Further mutational analyses of the three serines in this domain confirmed that Ser-333 and Ser-334 play a major role in these agonist-promoted changes in P2Y4-R. Experiments were carried out with [(32)P]P(i)-labeled cells to ascertain the role of phosphorylation in regulation of P2Y4-R. Incubation with UTP for 2 min caused a marked increase in phosphorylation of both the wild-type P2Y4-R and the P2Y4-343 truncation mutant. In contrast, no UTP-promoted phosphorylation of the P2Y4-332 truncation mutant was observed. Taken together, these results demonstrate differential regulation of uridine nucleotide-activated P2Y4-R and P2Y6-R and indicate that Ser-333 and Ser-334 in the carboxyl terminus of P2Y4-R are important for UTP-dependent phosphorylation, desensitization, and loss of surface receptors.

Highlights

  • Agonist-promoted regulation of the uridine nucleotideactivated human P2Y4 receptor (P2Y4-R) and P2Y6 receptor (P2Y6-R) was studied

  • Pharmacological studies indicated that neither protein kinase C nor other Ca2؉-activated kinases were involved in agonist-promoted desensitization or loss of surface P2Y4-R or P2Y6-R

  • No UTPpromoted phosphorylation of the P2Y4–332 truncation mutant was observed. These results demonstrate differential regulation of uridine nucleotideactivated P2Y4-R and P2Y6-R and indicate that Ser-333 and Ser-334 in the carboxyl terminus of P2Y4-R are important for UTP-dependent phosphorylation, desensitization, and loss of surface receptors

Read more

Summary

The abbreviations used are

P2Y-R, P2Y receptor; GPCR, G-proteincoupled receptor; GRK, G-protein-coupled receptor kinase; PCR, polymerase chain reaction; HA, hemagglutinin A; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; HBSS, Hanks’ buffered saline solution; BSA, bovine serum albumin; TPCK, L-1-tosylamido-2-phenylethyl chloromethyl ketone; Ins[1,4,5]P3, inositol 1,4,5-trisphosphate. Over, P2Y4-R and P2Y6-R differ markedly in potential sites for phosphorylation by second messenger-regulated kinases and GRKs. we initiated a comparative examination of the agonist-promoted changes in the activities of these receptors and of the mechanisms that underlie these changes. Major differences in the mechanisms of regulation of P2Y4-R versus. We report identification of two adjacent serines in the carboxyl terminus of the P2Y4-R receptor that play a major role in agonist-dependent phosphorylation, desensitization, and internalization of this receptor

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call